These findings provide further evidence for the involvement of bacterial products in surgery-associated accelerated growth in metastatic disease and justify either selective or collective targeting of LPS, TLR-4 and the u-PA system in the perioperative period to attenuate surgery-induced accelerated metastatic tumour growth. Here, TLR4 is linked to metastatic neoplasm.